Physician

Helen C Daniel-Glave, MD

According to 2025 Medicare claims, Helen Daniel-Glave, MD (NPI: 1467689158) practices internal medicine in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is ASSOCIATED CLINICIANS OF EAST TEXAS (NPI: 1932640349; TIN: 352585434) and primary practice location at 75605-2411. Daniel-Glave is affiliated with the Prime Care Managers, LLC (ACO ID: A3280) and CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Daniel-Glave's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 283 traditional Medicare patients, billed 6,038 HCPCS/CPT codes, and received $162,535 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 14,262 prescription claims across 587 beneficiaries totaling $1,187,618 in drug costs, led by Ozempic (Semaglutide). DME data shows 217 claims. Open Payments data shows 35 records totaling $635. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $262,596 to $162,535. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $37,717 to $13,838.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	442	10,248	$262,596
2016	442	9,609	$230,767
2017	422	9,210	$217,303
2018	387	1,841	$124,681
2019	379	2,473	$114,893
2020	360	1,743	$97,175
2021	325	1,567	$108,844
2022	295	1,803	$103,919
2023	285	1,599	$102,684
2024	283	6,038	$162,535

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	581	16,706	$928,663
2016	544	16,274	$932,583
2017	545	16,442	$976,711
2018	555	15,773	$993,139
2019	553	15,159	$1,021,796
2020	561	15,728	$1,047,748
2021	547	14,880	$1,043,774
2022	538	14,575	$1,150,862
2023	556	14,985	$1,326,024
2024	587	14,262	$1,187,618

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	218	921	$39,278
2016	136	737	$27,052
2017	106	560	$21,899
2018	57	468	$15,540
2019	46	489	$19,386
2020	55	459	$17,243
2021	84	333	$12,037
2022	18	253	$12,057
2023	13	190	$10,708
2024	N/R	217	$3,755

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	231	231	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	263	587	$82
80061	Blood test, lipids (cholesterol and triglycerides)	230	311	$13
80053	Blood test, comprehensive group of blood chemicals	239	338	$10
36415	Insertion of needle into vein for collection of blood sample	244	374	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	131	5,550	$179,820
Mounjaro	Tirzepatide	96	3,264	$118,316
Jardiance	Empagliflozin	110	5,608	$108,382
Eliquis	Apixaban	83	3,700	$70,410
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	2,760	$57,605

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	41	$1,123
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	16	$778
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	19	$466
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	24	$340
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	26	$293

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$635	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Helen C. Daniel-Glave, MD?

Tedicare shows public-source Medicare data for Helen C. Daniel-Glave, MD (NPI 1467689158), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Helen C. Daniel-Glave, MD have ACO affiliation data?

Helen C. Daniel-Glave, MD is shown with ACO affiliation data for Prime Care Managers, LLC (MSSP, ACO ID A3280) and CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Helen C. Daniel-Glave, MD?

Helen C. Daniel-Glave, MD is linked to ASSOCIATED CLINICIANS OF EAST TEXAS (billing NPI 1932640349) in the available physician profile data.

Does Helen C. Daniel-Glave, MD have Open Payments data?

Helen C. Daniel-Glave, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.